Genmab price target maintained at $40 by HC Wainwright
HC Wainwright & Co. maintained a $40.00-per-share price target for Genmab, as cited by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.